Comparing Selection on S. aureus between Antimicrobial Peptides and Common Antibiotics

PLoS ONE

Volumn 8, Issue 10, 2013, Pages

  Dobson, Adam J ^a,b   Purves, Joanne ^a,c   Kamysz, Wojciech ^d   Rolff, Jens ^a,e  

^a UNIVERSITY OF SHEFFIELD   (United Kingdom)

^b Department of Obstetrics Gynecology   (United States)

^c UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^d MEDICAL UNIVERSITY OF GDANSK   (Poland)

^e FREIE UNIVERSITÄT BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ISEGANAN; MELITTIN; PEXIGANAN; POLYPEPTIDE ANTIBIOTIC AGENT; STREPTOMYCIN; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BIOFILM; CHEMICAL REACTION KINETICS; CLINICAL PROTOCOL; CONTROLLED STUDY; GENE CASSETTE; GENETIC VARIABILITY; IMMUNE RESPONSE; IMMUNE SYSTEM; IN VITRO STUDY; MINIMUM INHIBITORY CONCENTRATION; MOLECULAR EVOLUTION; NONHUMAN; PHYLOGENY; PLEIOTROPY; STAPHYLOCOCCUS AUREUS;

ANTI-BACTERIAL AGENTS; ANTIMICROBIAL CATIONIC PEPTIDES; DRUG RESISTANCE, BACTERIAL; HUMANS; INHIBITORY CONCENTRATION 50; MICROBIAL SENSITIVITY TESTS; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; TIME FACTORS; VANCOMYCIN;

EID: 84885723371     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0076521     Document Type: Article

References (28)

1. Weigel LM, (2003) Genetic Analysis of a High-Level Vancomycin-Resistant Isolate of Staphylococcus aureus. Science 302: 1569-1571 doi:10.1126/science.1090956.
2. Prajsnar TK, Hamilton R, Garcia-Lara J, McVicker G, Williams A, et al. (2012) A privileged intraphagocyte niche is responsible for disseminated infection of Staphylococcus aureus in a zebrafish model. Cellular Microbiology 14: 1600-1619 doi:10.1111/j.1462-5822.2012.01826.x.
3. Zasloff M, (2002) Antimicrobial peptides of multicellular organisms. Nature 415: 389-395 doi:10.1038/415389a.
4. Brogden KA, (2005) Antimicrobial peptides: pore formers or metabolic inhibitors in bacteria? Nat Rev Microbiol 3: 238-250.
5. Pränting M, Negrea A, Rhen M, Andersson DI, (2008) Mechanism and fitness costs of PR-39 resistance in Salmonella enterica serovar Typhimurium LT2. Antimicrob Agents Chemother 52: 2734-2741 doi:10.1128/AAC.00205-08.
6. Tzou P, Reichhart J-M, Lemaitre B, (2002) Constitutive expression of a single antimicrobial peptide can restore wild-type resistance to infection in immunodeficient Drosophila mutants. Proc Natl Acad Sci USA 99: 2152-2157 doi:10.1073/pnas.042411999.
7. Login FH, Balmand S, Vallier A, Vincent-Monegat C, Vigneron A, et al. (2011) Antimicrobial Peptides Keep Insect Endosymbionts Under Control. Science 334: 362-365 doi:10.1126/science.1209728.
8. Perron GG, Zasloff M, Bell G, (2006) Experimental evolution of resistance to an antimicrobial peptide. Proceedings of the Royal Society B: Biological Sciences 273: 251-256 doi:10.1098/rspb.2005.3301.
9. Pränting M, Andersson DI, (2010) Mechanisms and physiological effects of protamine resistance in Salmonella enterica serovar Typhimurium LT2. Journal of Antimicrobial Chemotherapy 65: 876-887 doi:10.1093/jac/dkq059.
10. Habets MGJL, Rozen DE, Brockhurst MA, (2012) Variation in Streptococcus pneumoniae susceptibility to human antimicrobial peptides may mediate intraspecific competition. Proceedings of the Royal Society B: Biological Sciences 279: 3803-3811 doi:10.1098/rspb.2012.1118.
11. Gruenheid S, Le Moual H, (2012) Resistance to antimicrobial peptides in Gram-negative bacteria. FEMS Microbiology Letters 330: 81-89 doi:10.1111/j.1574-6968.2012.02528.x.
12. Bell G, (2003) Arming the enemy: the evolution of resistance to self-proteins. Microbiology 149: 1367-1375 doi:10.1099/mic.0.26265-0.
13. Habets MGJL, Brockhurst MA, (2012) Therapeutic antimicrobial peptides may compromise natural immunity. Biology Letters 8: 416-418 doi:10.1098/rsbl.2011.1203.
14. Zdybicka-Barabas A, Mak P, Klys A, Skrzypiec K, Mendyk E, et al. (2012) Biochimica et Biophysica Acta. BBA- Biomembranes 1818: 2623-2635 doi:10.1016/j.bbamem.2012.06.008.
15. Shaw LN, Aish J, Davenport JE, Brown MC, Lithgow JK, et al. (2006) Investigations into sigmaB-modulated regulatory pathways governing extracellular virulence determinant production in Staphylococcus aureus. Journal of Bacteriology 188: 6070-6080 doi:10.1128/JB.00551-06.
16. Andrès E, (2011) Cationic antimicrobial peptides in clinical development, with special focus on thanatin and heliomicin. Eur J Clin Microbiol Infect Dis 31: 881-888 doi:10.1007/s10096-011-1430-8.
17. Gottler LM, Ramamoorthy A, (2009) Structure, membrane orientation, mechanism, and function of pexiganan-a highly potent antimicrobial peptide designed from magainin. Biochim Biophys Acta 1788: 1680-1686 doi:10.1016/j.bbamem.2008.10.009.
18. Bolintineanu D, Hazrati E, Davis HT, Lehrer RI, Kaznessis YN, (2010) Antimicrobial mechanism of pore-forming protegrin peptides: 100 pores to kill E. coli. Peptides 31: 1-8 doi:10.1016/j.peptides.2009.11.010.
19. Wiedman G, Herman K, Searson P, Wimley WC, Hristova K, (2013) Biochimica et Biophysica Acta. BBA- Biomembranes 1828: 1357-1364 doi:10.1016/j.bbamem.2013.01.021.
20. Steinem C, Galla HJ, Janshoff A, (2000) Interaction of melittin with solid supported membranes. Phys Chem Chem Phys 2: 4580-4585 doi:10.1039/b003865m.
21. Yeung ATY, Gellatly SL, Hancock REW, (2011) Multifunctional cationic host defence peptides and their clinical applications. Cell Mol Life Sci 68: 2161-2176 doi:10.1007/s00018-011-0710-x.
22. Giacometti A, Cirioni O, Ghiselli R, Mocchegiani F, D'Amato G, et al. (2003) Administration of protegrin peptide IB-367 to prevent endotoxin induced mortality in bile duct ligated rats. Gut 52: 874-878.
23. Chen J, Falla TJ, Liu H, Hurst MA, Fujii CA, et al. (2000) Development of protegrins for the treatment and prevention of oral mucositis: structure-activity relationships of synthetic protegrin analogues. Biopolymers 55: 88-98 doi:;10.1002/1097-0282(2000)55:1<88::AID-BIP80>3.0.CO;2-K.
24. Martinez JL, (2008) Antibiotics and Antibiotic Resistance Genes in Natural Environments. Science 321: 365-367 doi:10.1126/science.1159483.
25. Kahm M, Hasenbrink G, Lichtenberg-Fraté H, Ludwig J, Kschischo M, (2010) grofit: fitting biological growth curves with R. Journal of Statistical Software. 33: 1-21.
26. Chait R, Craney A (2007) Antibiotic interactions that select against resistance. Nature.
27. Yeh PJ, Hegreness MJ, Aiden AP, Kishony R, (2009) Drug interactions and the evolution of antibiotic resistance. Nat Rev Microbiol 7: 460-466 doi:10.1038/nrmicro2133.
28. Fischbach MA (2011) Combination therapies for combating antimicrobial resistance. Curr Opin Microbiol.